The per capita market size value for Penicillins and Streptomycins in Dosage in the US stood at $13 in 2023. Based on forecasts, it is expected to rise slightly each year, reaching $13.18 by 2028. The year-on-year growth from 2024 is approximately 0.23%. This suggests a stable, yet modest growth trend over the forecast period.

Future trends to watch for include:

Potential impacts of healthcare policy changes on antibiotic usage.
Emergence of antibiotic resistance affecting demand dynamics.
Technological advancements in drug delivery systems potentially influencing market value.
Shifts in healthcare focus towards preventive measures possibly impacting future consumption.